Table II.
Outcomes | CMV disease | No. | Events | Total follow-up duration [years] | IR* | Odds ratio (95% CI) | |||
---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | Model 4 | ||||||
MI | No | 6,670 | 49 | 21,644.42 | 2.264 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 667 | 10 | 2,048.02 | 4.883 | 2.16 (1.03–4.08) | 2.21 (1.05–4.17) | 2.23 (1.07–4.22) | 2.14 (1.01–4.52) | |
CHF | No | 6,670 | 52 | 21,681.55 | 2.400 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 667 | 17 | 2,040.14 | 8.333 | 3.47 (1.95–5.87) | 3.62 (2.03–6.12) | 3.73 (2.09–6.31) | 3.79 (2.10–6.84) | |
AF | No | 6,670 | 58 | 21,605.37 | 2.685 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 667 | 9 | 2,048.60 | 4.393 | 1.63 (0.75–3.12) | 1.69 (0.78–3.24) | 1.70 (0.79–3.26) | 1.89 (0.90–3.96) |
Model 1 – non-adjusted, Model 2 – age- and sex-adjusted, Model 3 – age-, sex-, low income status-, type 2 NIDDM-, hypertension- and dyslipidemia-adjusted, Model 4 –age-, sex-, low income status-, type 2 NIDDM-, hypertension-, dyslipidemia-, SOT- and HSCT-adjusted.
per 1,000 patients. AF – atrial fibrillation, CHF – congestive heart failure, CI – confidence interval, CMV – cytomegalovirus, HSCT – hematopoietic stem cell transplantation, IR – incidence rate, MI – myocardial infarction, NIDDM – non-insulin dependent diabetes mellitus, No. – number, Ref. – reference, SOT – solid organ transplantation.